Clinical and economic impact of school ‐based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis

ConclusionUniversal two‐dose nonavalent HPV vaccination for 11‐ to 12‐year‐old adolescent women is very cost‐effective in Singapore. Tweetable abstractNonavalent HPV vaccination of 11‐ to 12‐year‐old girls is cost‐effective in Singapore.
Source: BJOG: An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Tags: Health Economics Source Type: research